SIRT1 and Parkinson disease: However, it is of great importance to elucidate whether calcitriol treatment decreases the α-Syn protein aggregation in PD, affects other Sirt1-related pathways, or modulates neuroinflammatory endpoints, including cytokines, in future studies.